Aclaris Therapeutics Inc (ACRS) — Financial Flexibility Index
Aclaris Therapeutics Inc (ACRS) has a Financial Flexibility Index of -0.20x as of September 2025. Free cash flow of $-10.91 Million (operating CF $-10.93 Million minus capex $23.00K) represents 0% of total liabilities ($55.43 Million). Also explore ACRS net assets growth trend to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Aclaris Therapeutics Inc Financial Flexibility Index (2013–2024)
Historical Financial Flexibility Index trend for Aclaris Therapeutics Inc across 12 annual periods. Check ACRS strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Aclaris Therapeutics Inc (2013–2024)
Year-by-year free cash flow to debt coverage for Aclaris Therapeutics Inc. For the full company profile including market capitalisation, see how much is Aclaris Therapeutics Inc worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.31x | $-19.95 Million | $-20.07 Million | $64.77 Million | ▲ +83.9% |
| 2023 | -1.91x | $-77.02 Million | $-78.33 Million | $40.23 Million | ▼ -62.9% |
| 2022 | -1.18x | $-66.96 Million | $-67.57 Million | $56.98 Million | ▼ -22.2% |
| 2021 | -0.96x | $-51.83 Million | $-52.13 Million | $53.87 Million | ▲ +16.5% |
| 2020 | -1.15x | $-38.18 Million | $-38.63 Million | $33.13 Million | ▲ +65.5% |
| 2019 | -3.34x | $-94.83 Million | $-96.44 Million | $28.39 Million | ▼ -103.0% |
| 2018 | -1.65x | $-99.45 Million | $-100.81 Million | $60.44 Million | ▲ +43.8% |
| 2017 | -2.93x | $-53.43 Million | $-54.66 Million | $18.25 Million | ▲ +43.8% |
| 2016 | -5.21x | $-34.37 Million | $-34.60 Million | $6.59 Million | ▲ +59.2% |
| 2015 | -12.77x | $-19.86 Million | $-20.37 Million | $1.55 Million | ▼ -6646.9% |
| 2014 | -0.19x | $-7.22 Million | $-7.64 Million | $38.13 Million | ▲ +10.1% |
| 2013 | -0.21x | $-4.92 Million | $-4.92 Million | $23.37 Million | — |